4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-048905
SVP, Chief Accounting Officer sold 2,163 shares at an average $40.80 ($88,249)
- SVP, Chief Accounting Officer acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Huizenga Theodore Alan · SVP, Chief Accounting Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-07 | Exercise or conversion : show line 1 in the form | +2,000 | $21.00 | $42,000 | 25,777 | D |
| 2023-09-07 | Sale : show line 2 in the form | −2,000 | $41.00 | $82,000 | 23,777 | D |
| 2023-09-07 | Sale : show line 3 in the form | −163 | $38.34 | $6,249 | 23,614 | D |
| Open-market sales · 2,163 sh · avg $40.80 · $88,249 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-09-07 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −2,000 | 3,000 | D |
Loading xslF345X05/doc4.xml…